Style | Citing Format |
---|---|
MLA | N Orouji NEDA, et al.. "The Effect of a Traditional Product, Hazelnut-Zante Currant Mixture, on an Animal Model of Autism." Research Journal of Pharmacognosy, vol. 12, no. 3, 2025, pp. 49-66. |
APA | N Orouji NEDA, Mr Zarrindast Mohammad REZA, Ms Sadatshirazi Mitra SADAT, Ah Memari Amir HOSSEIN, M Karimi MEHRDAD, A Zargaran ARMAN (2025). The Effect of a Traditional Product, Hazelnut-Zante Currant Mixture, on an Animal Model of Autism. Research Journal of Pharmacognosy, 12(3), 49-66. |
Chicago | N Orouji NEDA, Mr Zarrindast Mohammad REZA, Ms Sadatshirazi Mitra SADAT, Ah Memari Amir HOSSEIN, M Karimi MEHRDAD, A Zargaran ARMAN. "The Effect of a Traditional Product, Hazelnut-Zante Currant Mixture, on an Animal Model of Autism." Research Journal of Pharmacognosy 12, no. 3 (2025): 49-66. |
Harvard | N Orouji NEDA et al. (2025) 'The Effect of a Traditional Product, Hazelnut-Zante Currant Mixture, on an Animal Model of Autism', Research Journal of Pharmacognosy, 12(3), pp. 49-66. |
Vancouver | N Orouji NEDA, Mr Zarrindast Mohammad REZA, Ms Sadatshirazi Mitra SADAT, Ah Memari Amir HOSSEIN, M Karimi MEHRDAD, A Zargaran ARMAN. The Effect of a Traditional Product, Hazelnut-Zante Currant Mixture, on an Animal Model of Autism. Research Journal of Pharmacognosy. 2025;12(3):49-66. |
BibTex | @article{ author = {N Orouji NEDA and Mr Zarrindast Mohammad REZA and Ms Sadatshirazi Mitra SADAT and Ah Memari Amir HOSSEIN and M Karimi MEHRDAD and A Zargaran ARMAN}, title = {The Effect of a Traditional Product, Hazelnut-Zante Currant Mixture, on an Animal Model of Autism}, journal = {Research Journal of Pharmacognosy}, volume = {12}, number = {3}, pages = {49-66}, year = {2025} } |
RIS | TY - JOUR AU - N Orouji NEDA AU - Mr Zarrindast Mohammad REZA AU - Ms Sadatshirazi Mitra SADAT AU - Ah Memari Amir HOSSEIN AU - M Karimi MEHRDAD AU - A Zargaran ARMAN TI - The Effect of a Traditional Product, Hazelnut-Zante Currant Mixture, on an Animal Model of Autism JO - Research Journal of Pharmacognosy VL - 12 IS - 3 SP - 49 EP - 66 PY - 2025 ER - |